XML 47 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock Options, Warrants and 401(k) Savings Plan
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options, Warrants and 401(k) Savings Plan


12. Stock Options, Warrants and 401(k) Savings Plan


The Company follows FASB ASC 718, Share Based Payment, which requires that the cost resulting from all share-based payment transactions be recognized in the Company’s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values.

 

The 1999 Stock Option Plan provided for the granting of up to 2,000,000 incentive and non-qualified stock options to employees, non-employee directors, consultants and advisors to the Company. In the case of options designated as incentive stock options, the exercise price of the options granted must be not less than the fair market value of such shares on the date of grant. Non-qualified stock options may be granted at any amount established by the Stock Option Committee or, in the case of Discounted Options issued to non-employee directors in lieu of any portion of an Annual Retainer, in accordance with a formula designated in the Plan. The 1999 Stock Option Plan terminated in February 2009 and no further stock options can be granted under the plan; however, options granted before the termination date may be exercised through their expiration date.


The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December 31, 2014, 2013 and 2012 and there was no unrecognized portion of expense at December 31, 2014.


A summary of stock options under the Company’s stock option plans follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2011 and 2012

 

645,000

 

 

$0.12 and $.45

 

 

$0.32

 

Options expired

 

400,000

 

 

0.45

 

 

0.45

 

Outstanding at December 31, 2013

 

245,000

 

 

0.12

 

 

0.12

 

Options expired

 

245,000

 

 

0.12

 

 

0.12

 

Outstanding at December 31, 2014

 

0

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

  

 

 

Option

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

 

 

 

 

 

Exercisable options at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options available for future grant:

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

0

 

 

 

 

 

 

 

 

 


At December 31, 2014, the Company had 802,365 warrants to purchase common stock of the Company outstanding at exercise prices ranging from $0.01 to $0.07 and expiring at various dates through July 2021. The warrants were granted from 2010 to 2013 to six individuals in conjunction with loans provided to the Company, to ten investors who acquired convertible debentures from the Company in 2013 and 2014 and, in 2011, to a professional services provider related to certain fee payment considerations granted by the individual.


A summary of outstanding warrants follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2011

 

85,500

 

 

$0.045 to $0.07

 

 

$0.061

 

Warrants granted

 

47,000

 

 

0.01 to 0.07

 

 

0.036

 

Outstanding at December 31, 2012

 

132,500

 

 

0.01 to 0.07

 

 

0.052

 

Warrants granted

 

528,000

 

 

0.02 and 0.021

 

 

0.02

 

Outstanding at December 31, 2013

 

660,500

 

 

0.01 to 0.07

 

 

0.026

 

Warrants granted

 

166,365

 

 

0.02

 

 

0.02

 

Warrants canceled

 

24,500

 

 

0.03 and 0.07

 

 

0.037

 

Outstanding at December 31, 2014

 

802,365

 

 

$0.01 to $0.07

 

 

$0.025

 

 

  

 

 

 

 

 

 

 

 

 

 

  

Weighted average remaining contractual life (years)

 

5.21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Exercise

 

 

 

Average

 

 

 

 

 

 

 

Price Range

 

 

 

Exercise

 

 

 

Shares

 

 

 

Per Share

 

 

 

Price

 

Exercisable warrants at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2014

 

111,000

 

 

$0.01 to $0.07

 

 

$0.055

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

1.33

 

 

 

 

 

 

 

 

 


At December 31, 2014, the Company has reserved 3,955,005 shares of common stock for possible future issuance upon exercise of 802,365 warrants and for the conversion of approximately $138,300 convertible debentures and accrued interest into 3,152,640 shares of common stock.


The Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of the Company. There were no contributions charged to expense during 2014, 2013 or 2012.